Navigation Links
New technique for cancer screening

Graz, Austria Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples. The related report by Balic et al, "High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis," appears in the March 2009 issue of The Journal of Molecular Diagnostics.

DNA in tumors is often altered compared with DNA in normal tissues. One common DNA alteration in cancerous tissue is hypermethylation, which results in loss of gene expression. The difference in methylation between normal and cancerous tissues can be used as a biomarker for early cancer diagnosis, risk assessment, and response to therapy.

Archival tissues, or tissues that are formalin-fixed and paraffin-embedded for long-term storage, are difficult to screen for cancer biomarkers due to the low quality of their DNA. It is therefore important to develop new techniques to screen for DNA methylation that can be used in archival tissues.

Balic and colleagues examined the ability of high-resolution melting analysis (HRM) to detect methylation on archival tissues from colorectal cancer patients. They found that HRM provided similar results between archival and fresh tissues. In addition, they validated the results using the widely used MethyLight assay.

The results by Balic et al "add substantial information on the HRM-based DNA methylation analysis and demonstrate its applicability for analysis of archival tissues." This assay can be used to establish risk stratification of patients based on methylation status of specific markers and, due to its high sensitivity may have the potential to detect low amounts of methylated cells within the tumor, or even to detect low numbers of tumor cells in the background of non-tumor cells in lymph nodes and other organs. Most importantly, because formalin fixation and paraffin embedding are the most common means of tissue storage, the reported method has the potential to make DNA methylation analysis possible on this vast tissue resource.

Balic and colleagues will now evaluate the ability of HRM-based DNA methylation analysis to predict the presence of lymph node metastases and to detect very small tumor deposits in lymph nodes with known micrometastatic disease in a well defined cohort of prostate cancer samples. This may lead to new and better predictive and staging methods for prostate cancer patients.


Contact: Angela Colmone
American Journal of Pathology

Related biology news :

1. New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
2. U of T technique put to use to test clean up of contaminated groundwater
3. New satellite techniques for looking at climate change
4. New computational technique allows comparison of whole genomes as easily as whole books
5. Novel technique changes lymph node biopsy, reduces radiation exposure
6. Novel technique changes lymph node biopsy, reduces radiaiton exposure
7. New technique is quantum leap forward in understanding proteins
8. New edition of laboratory manual includes cutting-edge techniques to study gene regulation
9. Novel technique for fluorescence tomography of tumors in living animals
10. These shells dont clam up: Innovative technique to record human impact on coastal waters
11. Einstein researchers develop technique to count messages made by single genes
Post Your Comments:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: